June 7 | 2022 2cureX AB announces share purchase by the company’s Chairman of the Board of Directors and Executive Management Read more
May 20 | 2022 We invite you to join the 2cureX Q1 Report webcast and Q&A session at 15:00 on 24 May, 2022 Read more
May 9 | 2022 2cureX presents IndiTreat® clinical results at the Society for Functional Precision Medicine Read more
May 6 | 2022 2cureX appoints Sedermera Corporate Finance AB to act as a liquidity provider for the Company´s share Read more
April 22 | 2022 Correction of “Notice of annual general meeting of 2cureX AB (publ)” issued on 21st April 2022 Read more
April 21 | 2022 Manuel Fernández joins 2cureX as Director of Quality Assurance and Regulatory Affairs. Read more
April 14 | 2022 Chairman of the 2cureX Board exercises all warrants within the framework of the 2018 incentive program Read more